Biomarkers Market size was valued at USD 45.1 billion in 2022 and is projected to reach USD 98.2 billion by 2029 at a CAGR of 12.2% during the forecast period 2023 to 2029. Biomarkers are cellular or molecular diagnostic tools, measured in in biological samples, for instance, urine, stool and blood. It is utilized as an indicator to check and assess biological, pharmacological and pathogenic procedures. Biomarkers range from proteins, lipids, carbohydrates, RNA, DNA, hormones, platelets etc. Currently wide range of biomarkers market are available for the different systems such as cardiovascular, metabolic system and immune system. Biomarkers not only help in diagnosis of the disease but also helps in tracking progression, regression and outcome after the intervention.

https://www.precisionbusinessinsights.com/market-reports/biomarkers-market